biospecimen_aliquot__bcr_aliquot_barcode	tcga-ew-a1pg-01a-11d-a142-09
biospecimen_aliquot__bcr_aliquot_uuid	bd3801e2-c5bb-4116-9ce3-97903fc6956e
biospecimen_aliquot__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_aliquot__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474723
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-04-06
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a142
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.98
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ew-a1pg-01a-11d
biospecimen_analyte__bcr_analyte_uuid	fc0b8abf-e4d9-46ec-84cd-e758332f76cc
biospecimen_analyte__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_analyte__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ew-a1pg
biospecimen_diagnostic_slides__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	a31b2048-d04d-467c-a9e4-6a63942a58c6
biospecimen_normal_control__bcr_patient_barcode	tcga-ew-a1pg
biospecimen_normal_control__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_portion__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_portion__bcr_portion_barcode	tcga-ew-a1pg-01a-11
biospecimen_portion__bcr_portion_uuid	b6d9b351-a0c3-4ea2-b693-ccce1f776653
biospecimen_portion__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_portion__date_of_creation	2011-03-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ew-a1pg-01a-11d
biospecimen_protocol__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_protocol__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_sample__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_sample__bcr_sample_uuid	e216aa55-98fc-4d0d-a24e-cfa05778f973
biospecimen_sample__days_to_collection	829
biospecimen_sample__initial_weight	210
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ew-a1pg.6197798c-6f04-470e-ba91-922548e2dfaf.pdf
biospecimen_sample__pathology_report_uuid	6197798c-6f04-470e-ba91-922548e2dfaf
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	6621baf4-3dc5-4905-99b2-f40d75886fa0
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ew-a1pg-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
biospecimen_slide__bcr_sample_barcode	tcga-ew-a1pg-01a
biospecimen_slide__bcr_slide_barcode	tcga-ew-a1pg-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	2e6d10d1-ae2a-4ca4-9f75-e9fe64e32b70
biospecimen_slide__image_file_name	tcga-ew-a1pg-01a-01-tsa.2e6d10d1-ae2a-4ca4-9f75-e9fe64e32b70.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	3
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	5
biospecimen_slide__percent_stromal_cells	25
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ew-a1pg
biospecimen_tumor_sample__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
clinical_drug__bcr_drug_barcode	tcga-ew-a1pg-d29104
clinical_drug__bcr_drug_uuid	252a2a60-d59f-40fc-b2af-72551b1d46f1
clinical_drug__bcr_patient_barcode	tcga-ew-a1pg
clinical_drug__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
clinical_drug__form_completion_date	2012-3-8
clinical_drug__pharma_adjuvant_cycles_count	3
clinical_drug__pharmaceutical_therapy_drug_name	fluorouracil
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	262
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	157
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	910
clinical_drug__regimen_number	fec x3 then t x3
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	2730
clinical_follow_up__bcr_followup_barcode	tcga-ew-a1pg-f29103
clinical_follow_up__bcr_followup_uuid	8ba6c3bb-bf54-4173-8fd5-bd3a864ea6ec
clinical_follow_up__bcr_patient_barcode	tcga-ew-a1pg
clinical_follow_up__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-8
clinical_follow_up__last_contact_days_to	1051
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	53
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower inner quadrant|left lower outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ew-a1pg
clinical_patient__bcr_patient_uuid	da286247-e8bb-4941-a2af-2453fe61cd02
clinical_patient__birth_days_to	-19464
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	hispanic or latino
clinical_patient__form_completion_date	2011-5-18
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.8
clinical_patient__her2_copy_number	<4.0
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	10-19%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	876
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	25
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__lymph_nodes_examined_ihc_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a1pg
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ew
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1PG-01A-11D-A142-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1PG-01A-11D-A142-09.bed.meta
manually_curated__id	tcga-ew-a1pg-01a-11d-a142-09
manually_curated__md5sum	ef15c7e606dd8d4726614f2bce29c1cd
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	bd3801e2-c5bb-4116-9ce3-97903fc6956e
manually_curated__tumor_tag	brca
